Very Low Density Lipoprotein Turnover in Young and Elderly Individuals

Aging Clinical Trial

Official title:

Very Low Density Lipoprotein Turnover in Young and Elderly Individuals

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02113215
• Other study ID #: 11-318
• Secondary ID: 1R01AG033761-01A
• Status: Recruiting
• Phase: N/A
• First received: April 10, 2014
• Last updated: April 10, 2014
• Start date: December 2011
• Est. completion date: July 2015

Study information

• Verified date: April 2014
• Source: The University of Texas Medical Branch, Galveston
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Intrahepatic and intramyocellular lipid concentrations are elevated in elderly individuals relative to young people, despite no significant difference in fasting plasma TAG concentrations. Our general hypothesis is that the increase in intrahepatic fat with age results from reduced VLDL turnover, and therefore elderly individuals in this study will display lower VLDL turnover rates than young individuals. The aims of this study are a) to compare VLDL turnover in young and elderly individuals, and b) to compare a bolus method and a constant infusion method of assessing VLDL turnover.

Description:

Several studies have shown an association between hypertriacylglycerolaemia and coronary artery disease. Additionally, ectopic fat distribution, in particular, deposition of excess lipid within the liver and skeletal muscle, has been shown to correlate negatively with insulin sensitivity, thus presenting a metabolic milieu in which risk of developing type 2 diabetes is elevated. Previous research from our group has shown that the triacylglycerol (TAG) concentration within the liver, and within skeletal muscle fibres IMCLs (intramyocellular lipids), is increased in elderly individuals compared with young people. The elevation of lipids in these particular tissues for the elderly group was observed despite no statistically significant difference in fasting plasma TAG concentration. As the plasma TAG concentration during the postabsorptive state is largely determined by the production and clearance rates of very low density lipoprotein triacylglycerol (VLDL-TAG), and increased liver fat content has been shown to drive production of large VLDL particles, it is important to gain an understanding of whether VLDL synthesis and breakdown differs between young and elderly individuals. Such new knowledge may offer an insight into why tissue lipids are elevated in the elderly. At present, no data exist in the literature describing VLDL turnover in elderly people. We hypothesise that very low density lipoprotein turnover will be reduced in elderly individuals compared with young people. The aims of this study are a) to determine whether fractional synthesis and breakdown rates of both the protein and lipid parts of the VLDL are different between young and elderly individuals, and b) to determine whether VLDL turnover values appear different when calculated using a constant infusion tracer method as compared with a bolus tracer method. Eight young men, eight young women, eight elderly men and eight elderly women will each participate in an 8-hour infusion study. Stable isotopes of glycerol, amino acids and fatty acids will be infused, and blood samples will be drawn in intervals during the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: July 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 60 Years to 75 Years

Eligibility

Inclusion Criteria:

• Age 18 to 35 years, or 60 to 75 years.

• Body mass index = 27 kg•m2

• Ability to sign informed consent.

• Score of =26 for Mini-Mental State Exam

Exclusion Criteria:

• Diabetics (plasma glucose concentration >200 mg/dl at 2 hr after oral intake of 75 g glucose).

• Fasting plasma triacylglycerol concentration above 500 mg/dl

• Kidney disease.

• Liver disease.

• Bleeding disorders.

• Anaemia (Hb < 13 g/dl in males or < 12 g/dl in females).

• Endocrine disease (with the exception of well-regulated hypothyroidism).

• Positive hepatitis or HIV screens.

• Alcohol (CAGE questionnaire; abnormal liver enzyme values) or drug abuse (amphetamines, cocaine, opioids, marijuana).

• Lipid altering agents.

• Score of <26 for Mini-Mental State Exam

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Aging

Intervention

Procedure:
• Stable Isotope Infusion
9-hour infusion of stable isotope tracers

Locations

Country	Name	City	State
United States	University of Texas Medical Branch, Dept of Surgery	Galveston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
The University of Texas Medical Branch, Galveston	National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Very Low Density Lipoprotein (VLDL) Turnover	Turnover rates of VLDL-triglycerides and VLDL-ApoB (apolipoprotein B)-100, including synthesis and breakdown rates, measured during a 9-hour infusion trial.	9-hours	No